Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
기사 요약
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
신뢰할 수 있는 매체의 최신 소식을 간단한 요약과 함께 확인하세요. 자세한 내용은 원문 링크를 여세요.